NCT01364051 2026-03-18Cediranib Maleate and Selumetinib Sulfate in Treating Patients With Solid MalignanciesNational Cancer Institute (NCI)Phase 1 Active not recruiting19 enrolled
NCT00600496 2025-11-13A Phase I, Open-Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6244 (ARRY-142886)AstraZenecaPhase 1 Active not recruiting140 enrolled